Review
Multidisciplinary Sciences
Pooya Afaghi, Michael Anthony Lapolla, Khashayar Ghandi
Summary: Microwave ablation (MWA) is a safe and effective method for treating tumors, with higher completion rates for smaller tumors. Different frequencies, specifically 915 MHz and 2.45 GHz, may be more effective for ablating large tumors. Liver function tests are recommended for COVID-19 patients with hepatic tumors undergoing MWA to monitor potential liver injury.
Article
Radiology, Nuclear Medicine & Medical Imaging
Sonam Tashi, Apoorva Gogna, Sum Leong, Nanda Venkatanarasimha, Sivanathan Chandramohan
Summary: Percutaneous thermal ablation is considered a safe and cost-effective treatment option for hepatic tumors. However, there are various vascular and non-vascular complications that can occur post-ablation. This review focuses on the vascular complications and discusses strategies for prevention and management.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Sebastian Zensen, Arno Buecker, Mathias Meetschen, Johannes Haubold, Marcel Opitz, Jens M. Theysohn, Sara Schramm, Leonie Jochheim, Stefan Kasper, Michael Forsting, Benedikt Michael Schaarschmidt
Summary: A total of 7228 liver tumor ablations from 136 centers in Germany and Austria were analyzed. The technical success rate is high, with microwave ablation showing a higher success rate than radiofrequency ablation, but the latter has a lower rate of complications.
EUROPEAN RADIOLOGY
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Jianxiang Zhang, Kaihao Xu, Kepu Du, Xinwei Han, Dechao Jiao
Summary: Simultaneous percutaneous microwave ablation (MWA) and percutaneous biopsy (PB) for highly suspected malignant pulmonary nodules (PNs) is a safe and effective strategy that reduces bleeding, patient exposure dose, hospitalization time, and costs.
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY
(2023)
Review
Gastroenterology & Hepatology
Hitoshi Maruyama, Maki Tobari, Hiroaki Nagamatsu, Tadashi Yamaguchi, Shuichiro Shiina
Summary: Percutaneous ablation under imaging guidance is an effective minimally invasive treatment for liver cancer and benign liver tumors, with good treatment outcomes and low risk of complications.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY
(2023)
Article
Oncology
Eren Berber, Serkan Akbulut
Summary: The study evaluated a new 150 W microwave ablation system for liver tumor treatment, demonstrating that it significantly reduced ablation time and created larger ablation zones with a single stick compared to the 100 W system. The results showed promising feasibility, safety, and efficacy in achieving complete tumor destruction at short-term follow-up.
JOURNAL OF SURGICAL ONCOLOGY
(2022)
Article
Urology & Nephrology
Joseph B. John, Moira Anderson, Thomas Dutton, Mark Stott, Malcolm Crundwell, Rhys Llewelyn, Andrew Gemmell, Rory Bufacchi, Alexander Spiers, Nicholas Campain
Summary: This study reports on a tertiary referral center's experience with microwave ablation for suspected renal cell carcinoma, detailing complications and oncological outcomes. The results showed that MWA was well tolerated for T1a/small T1b renal masses, with 95% of patients discharged the following day and low complication rates, and favorable disease control observed in current follow-up.
Article
Radiology, Nuclear Medicine & Medical Imaging
Ismail Tahir, Alexis M. Cahalane, Jonathan A. Saenger, Konstantin S. Leppelmann, Maya Abrishami Kashani, J. Peter Marquardt, Stuart G. Silverman, Paul B. Shyn, Nathaniel D. Mercaldo, Florian J. Fintelmann
Summary: This study aimed to investigate the association between established risk factors in the surgical literature and hospital length of stay (HLOS), adverse events, and hospital readmission within 30 days after percutaneous image-guided thermal ablation of lung tumors. The results showed that chronic obstructive pulmonary disease (COPD) and general anesthesia were the only risk factors associated with longer HLOS.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
(2023)
Article
Medicine, General & Internal
Athanasios Tsochatzis, Argyro Mazioti, Georgios Iliadis, Georgios Velonakis, Evgenia Efthymiou, Alexis Kelekis, Nikolaos Kelekis, Dimitrios Filippiadis
Summary: This study compared the sphericity index parameters of ablation zones following microwave ablation in cirrhotic and healthy liver parenchyma, showing significant differences in short axis diameter between the two groups but no significant differences in sphericity index. On one-month follow-up, ablation zones tended to become more ellipsoidal in healthy livers while remaining stable in cirrhotic livers.
Article
Biochemistry & Molecular Biology
Marija Radmilovic-Radjenovic, Nikola Boskovic, Martin Sabo, Branislav Radjenovic
Summary: Simulation techniques play an important role in microwave ablation for liver tumors, helping to determine optimal treatment conditions. This study developed a three-dimensional simulation model to tailor the microwave ablation process based on tumor shape and size, minimizing damage to surrounding healthy tissue.
Article
Radiology, Nuclear Medicine & Medical Imaging
Roberto Iezzi, Roberto Cioni, Domenico Basile, Nevio Tosoratti, Alessandro Posa, Marco Busso, Carla Cappelli, Stefano Margaritora, Marcello Carlo Ambrogi, Alessandra Cassano, Rossella Scandiffio, Marco Calandri, Laura Crocetti, Vincenzo Valentini, Riccardo Manfredi, Andrea Veltri
Summary: This study confirmed the reproducibility, safety, and efficacy of microwave ablation (MWA) for primary and secondary pulmonary tumors up to 4 cm in diameter. Immediate post-MWA CT scans showed slightly smaller ablation dimensions compared to ex vivo models, but a significant volumetric increase in the treated area was observed at 1 month post-ablation.
EUROPEAN RADIOLOGY
(2021)
Review
Medicine, General & Internal
Sadeer J. Alzubaidi, Harris Liou, Gia Saini, Nicole Segaran, J. Scott Kriegshauser, Sailendra G. Naidu, Indravadan J. Patel, Rahmi Oklu
Summary: Percutaneous image-guided lung ablation, including cryoablation, is considered a promising treatment option for lung tumors, with recent encouraging results in protocol optimization for cryoablation.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Oncology
Qinxian Zhao, Zhigang Cheng, Zhiyu Han, Fangyi Liu, Xiaoling Yu, Xianliang Tan, Bin Han, Jianping Dou, Jie Yu, Ping Liang
Summary: There were no significant differences in overall survival (OS) or disease-free survival (DFS) between the two groups. Percutaneous microwave ablation (PMWA) was associated with increased local tumor progression (LTP), fewer postoperative days, and fewer major complications.
FRONTIERS IN ONCOLOGY
(2021)
Article
Surgery
Umberto Cillo, Michele Finotti, Chiara Di Renzo, Alessandro Vitale, Giacomo Zanus, Enrico Gringeri, Alessandra Bertacco, Marina Polacco, Francesco D'Amico
Summary: Thoracoscopic trans-diaphragmatic ablation is a safe and effective treatment option for liver tumors, especially for patients with previous multiple abdominal surgeries. Post-operative mortality was 0%, with 83.3% of nodules achieving complete radiological response within 3 months.
FRONTIERS IN SURGERY
(2021)
Review
Radiology, Nuclear Medicine & Medical Imaging
Pankaj Gupta, Muniraju Maralakunte, Sathya Sagar, Praveen Kumar-M, Harish Bhujade, Sreedhara B. Chaluvashetty, Naveen Kalra
Summary: A systematic review of studies on irreversible electroporation (IRE) for liver malignancies showed that IRE is associated with favorable overall survival (OS) and progression-free survival (PFS), despite a high overall complication rate, with most complications being minor.
EUROPEAN RADIOLOGY
(2021)